86 related articles for article (PubMed ID: 6884214)
1. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
Wiechmann HW; Schuster P; Trieb G
Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
3. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH
Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166
[TBL] [Abstract][Full Text] [Related]
4. Dose dependence of tolerance during treatment with mononitrates.
Tauchert M; Jansen W; Osterspey A; Fuchs M; Hombach V; Hilger HH
Z Kardiol; 1983; 72 Suppl 3():218-28. PubMed ID: 6666225
[TBL] [Abstract][Full Text] [Related]
5. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I
Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331
[TBL] [Abstract][Full Text] [Related]
6. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
Wiechmann HW; Schuster P; Trieb G
Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
[No Abstract] [Full Text] [Related]
7. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
8. [Long-term therapy with nitrates. Relation between dosage and tolerance effect].
Tauchert M; Jansen W; Metternich M; Osterspey A
Herz; 1984 Jun; 9(3):153-65. PubMed ID: 6430769
[TBL] [Abstract][Full Text] [Related]
9. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Akhras F; Jefferies S; Jackson G
Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
Jansen W; Meyer L; Tauchert M
Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
[TBL] [Abstract][Full Text] [Related]
11. [Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
Jansen W; Prenzel R; Kümper H; Weidmann B; Tauchert M
Z Kardiol; 1989; 78 Suppl 2():72-8; discussion 115-7. PubMed ID: 2511697
[TBL] [Abstract][Full Text] [Related]
12. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.
Silber S; Vogler AC; Krause KH; Theisen K
Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317
[TBL] [Abstract][Full Text] [Related]
13. Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
Jansen W; Prenze R; Kümper H; Tauchert M
Am J Cardiol; 1990 Jun; 65(21):16J-22J. PubMed ID: 2349913
[TBL] [Abstract][Full Text] [Related]
14. Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.
Ganzinger U
Arzneimittelforschung; 1992 Mar; 42(3):307-10. PubMed ID: 1497689
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
[No Abstract] [Full Text] [Related]
17. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
18. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
19. Coronary artery dilation and hemodynamic responses after isosorbide dinitrate therapy in patients with coronary artery disease.
Badger RS; Brown BG; Gallery CA; Bolson EL; Dodge HT
Am J Cardiol; 1985 Sep; 56(7):390-5. PubMed ID: 4036818
[TBL] [Abstract][Full Text] [Related]
20. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
